Tirzepatide overdose caused life-threatening complications requiring ICU and prolonged rehabilitation | Research

The takeaway

A 39-year-old man with no comorbidities developed life-threatening hypoglycemia, pancytopenia, aspiration pneumonia, and multiorgan dysfunction from unsupervised rapid tirzepatide dose escalation for weight loss, requiring ICU ventilation, dialysis, tracheostomy, and neurorehabilitation.

Life-threatening overdose
A previously healthy man developed multiorgan failure from unsupervised tirzepatide dose escalation—highlighting dangers of GLP-1 drug misuse

What the researchers found

Unsupervised rapid tirzepatide dose escalation in a 39-year-old without comorbidities caused life-threatening hypoglycemia, pancytopenia, electrolyte abnormalities, aspiration pneumonia, respiratory failure, septic shock, and multiorgan dysfunction requiring prolonged ICU stay.

Why it matters

As GLP-1 drugs become available through private prescribing and online pharmacies, unsupervised use and inappropriate dosing are increasing. This case demonstrates that overdose can be life-threatening even in young, healthy individuals.

How the study worked

Single case report documenting clinical course, complications, and management.

What this study cannot tell us

Single case report. Cannot determine exact dose or timeline of escalation. Other contributing factors may have been present. Rare extreme case may not represent typical overdose scenarios.

How to read the evidence

Single case report—lowest evidence level but critically important for safety awareness given expanding unsupervised use.

When this study was published

Published in 2025; directly relevant to current public health concerns about GLP-1 drug safety.

The bigger picture

This case is a stark warning as GLP-1 drugs become widely available outside traditional healthcare settings. The combination of powerful metabolic effects with inadequate medical oversight creates a dangerous situation, particularly in the UK where private prescribing is growing rapidly.

Questions still open

What dose of tirzepatide causes severe metabolic derangement?
Should GLP-1 drugs require stricter prescribing controls?
How common are severe adverse events from unsupervised GLP-1 use?

Common questions

Can you overdose on tirzepatide or semaglutide?

Yes. This case shows that taking too much tirzepatide too quickly can cause life-threatening complications including dangerously low blood sugar, organ failure, and blood cell depletion. These drugs have strict dose escalation schedules that must be followed under medical supervision.

Why is unsupervised GLP-1 drug use dangerous?

GLP-1 drugs are powerful metabolic agents that affect blood sugar, appetite, and multiple organ systems. Without medical monitoring, rapid dose increases can overwhelm the body's ability to compensate, leading to severe metabolic crises. This patient required ICU care for weeks despite being previously healthy.

Read the original research

Severe Adverse Effects of Tirzepatide Overdose Requiring Intensive Care Unit Admission and Complex Rehabilitation.

Cureus, 17(12), e98681

View on PubMed ↗Publisher’s paper ↗

Citation

Sharafeldin, Mahmoud; Alhamdan, Noor; Khaliq, Ayesha. (2025). Severe Adverse Effects of Tirzepatide Overdose Requiring Intensive Care Unit Admission and Complex Rehabilitation.. Cureus, 17(12), e98681. https://doi.org/10.7759/cureus.98681